Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty

American Journal of Cardiology

Volumn 107, Issue 2, 2011, Pages 179-185

  Oduncu, Vecih ^a   Tanalp, Ali Cevat ^a   Erkol, Ayhan ^a   Srma, Dicle ^a   Dndar, Cihan ^a   Akgn, Taylan ^a   Trkylmaz, Erdem ^a   Klgedik, Alev ^a   Gzbyk, Gkhan ^a   Tigen, Krat ^a   Izgi, Akn ^a   Krma, Cevat ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FLUINDOSTATIN; INSULIN; LIPID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR INFLAMMATION; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650863986     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.09.008     Document Type: Article

References (28)

1. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. G.C. Fonarow, R.S. Wright, F.A. Spencer, P.D. Fredrick, W. Dong, N. Every, W.J. French National Registry of Myocardial Infarction 4 Investigators Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality Am J Cardiol 96 2005 611 616
3. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
4. P.M. Ridker, N. Rifai, M. Clearfield, J.R. Downs, S.E. Weis, J.S. Miles, A.M. Gotto Jr Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
5. J.W. Son, K.K. Koh, J.Y. Ahn, D.K. Jin, G.S. Park, D.S. Kim, and E.K. Shin Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease Int J Cardiol 88 2003 77 82
6. S.P. Jones, Y. Teshima, M. Akao, and E. Marban Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes Circ Res 93 2003 697 699
7. R. Merla, N.K. Reddy, F.W. Wang, B.F. Uretsky, A. Barbagelata, and Y. Birnbaum Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis Am J Cardiol 100 2007 770 776
8. K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction Eur Heart J 27 2006 534 539
9. R. Hoffmann, P. Haager, H. Suliman, P. Christott, P. Radke, R. Blindt, and M. Kelm Effect of statin therapy before q-wave myocardial infarction on myocardial perfusion Am J Cardiol 101 2008 139 143
10. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306 (Pubitemid 28280383)
11. J.A. de Lemos, and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J Am Coll Cardiol 38 2001 1283 1294
12. T. Reffelmann, and R.A. Kloner The no-reflow phenomenon: basic science and clinical correlates Heart 87 2002 162 168
13. H. Ito, A. Okamura, K. Iwakura, T. Masuyama, M. Hori, S. Takiuchi, S. Negoro, Y. Nakatsuchi, Y. Taniyama, Y. Higashino, K. Fujii, and T. Minamino Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction Circulation 93 1996 1993 1999
14. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J Am Coll Cardiol 54 2009 281 292
15. D. Pruefer, R. Scalia, and A.M. Lefer Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats Arterioscler Thromb Vasc Biol 19 1999 2894 2900
16. A. Rezaie-Majd, G.W. Prager, R.A. Bucek, G.H. Schernthaner, T. Maca, H.G. Kress, P. Valent, B.R. Binder, E. Minar, and M. Baghestanian Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients Arterioscler Thromb Vasc Biol 23 2003 397 403
17. P. Libby, and M. Aikawa Mechanisms of plaque stabilization with statins Am J Cardiol 91 suppl 2003 S4B S8B
18. P.O. Bonetti, S.H. Wilson, M. Rodriguez-Porcel, D.R. Holmes, L.O. Lerman, and A. Lerman Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering J Am Coll Cardiol 40 2002 546 554 (Pubitemid 34833173)
19. D.H. Walter, K. Rittig, F.H. Bahlmann, R. Kirchmair, M. Silver, T. Murayama, H. Nishimura, D.W. Losordo, T. Asahara, and J.M. Isner Statin therapy accelerates re-endothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells Circulation 105 2002 3017 3024
20. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515
21. S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases Circ Res 90 2002 420 427
22. L.C. Thuc, Y. Teshima, N. Takahashi, Y. Nagano-Torigoe, K. Ezaki, K. Yufu, M. Nakagawa, M. Hara, and T. Saikawa Mitochondrial K+ ATP channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection Apoptosis 15 2010 669 678
23. M. Pastuszczak, A. Kotlarz, M. Mostowik, J. Zalewski, K. Zmudka, and A. Undas Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction Thromb Res 125 2010 382 386
24. K.A. Bybee, S.L. Kopecky, B.A. Williams, J.G. Murphy, and R. Scott Wright Reduced creatine kinase release with statin use at the time of myocardial infarction Int J Cardiol 96 2004 461 466
25. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys, and V. Gudnason C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
26. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
27. M. Griselli, J. Herbert, W.L. Hutchinson, K.M. Taylor, M. Sohail, T. Krausz, and M.B. Pepys C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1999 1733 1740
28. S. Ørn, C. Manhenke, T. Ueland, J.K. Dams, T.E. Mollnes, T. Edvardsen, P. Aukrust, and K. Dickstein C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction Eur Heart J 30 2009 1180 1186